An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes.
An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes.
复制标题
DOI:
10.1016/j.cels.2017.05.009
复制
发表时间:
2017-06-28
期刊:
影响因子:
9.3
通讯作者:
Olsen JV
中科院分区:
文献类型:
--
作者:
Bekker-Jensen DB;Kelstrup CD;Batth TS;Larsen SC;Haldrup C;Bramsen JB;Sørensen KD;Høyer S;Ørntoft TF;Andersen CL;Nielsen ML;Olsen JV
This study investigates the challenge of comprehensively cataloging the complete human proteome from a single-cell type using mass spectrometry (MS)-based shotgun proteomics. We modify a classical two-dimensional high-resolution reversed-phase peptide fractionation scheme and optimize a protocol that provides sufficient peak capacity to saturate the sequencing speed of modern MS instruments. This strategy enables the deepest proteome of a human single-cell type to date, with the HeLa proteome sequenced to a depth of ∼584,000 unique peptide sequences and ∼14,200 protein isoforms (∼12,200 protein-coding genes). This depth is comparable with next-generation RNA sequencing and enables the identification of post-translational modifications, including ∼7,000 N-acetylation sites and ∼10,000 phosphorylation sites, without the need for enrichment. We further demonstrate the general applicability and clinical potential of this proteomics strategy by comprehensively quantifying global proteome expression in several different human cancer cell lines and patient tissue samples. Multi-shot proteomics quantifies the protein levels of 12,200+ genes in HeLa cells This essentially complete HeLa proteome has coverage similar to next-gen RNA-seq Deep coverage of major PTMs is achieved without specific enrichment The approach is extendable to other human cell lines and patient samples Bekker-Jensen et al. show that proteomics can now provide an essentially complete HeLa proteome. They provide measurements acquired simultaneously for more than 12,200 protein-coding genes, 10,000 phosphorylation sites, and 7,000 N-acetylation sites. Their approach is fast, accessible, and requires modest amounts of starting material, making it easily extendable to other human cell lines and patient samples.